Kiniksa Pharmaceuticals International, plc (KNSA) Free cash flow 2017–2025
Kiniksa Pharmaceuticals International, plc (KNSA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$136.4MFY2025 · since FY2017: -$50.3M → $136.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $136.4M | +436.8% |
| FY2024 | $25.4M | +92.9% |
| FY2023 | $13.2M | +131.0% |
| FY2022 | $5.7M | +104.5% |
| FY2021 | -$126.7M | +7.4% |
| FY2020 | -$136.8M | +15.3% |
| FY2019 | -$161.6M | -87.2% |
| FY2018 | -$86.3M | -71.6% |
| FY2017 | -$50.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice